• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 10-Q filed by Locust Walk Acquisition Corp.

    8/8/25 4:16:50 PM ET
    $LWAC
    Get the next $LWAC alert in real time by email

     

     

    UNITED STATES 

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 10-Q

     

    (MARK ONE) 

     ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

     

    For the quarter ended March 31, 2025

     

    ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

     

    For the transition period from                    to                       

     

    Commission file number: 001-42714

     

    LightWave Acquisition Corp.

    (Exact Name of Registrant as Specified in Its Charter) 

     

    Cayman Islands   N/A
    (State or other jurisdiction of
    incorporation or organization)
      (I.R.S. Employer
    Identification No.)

     

    14755 Preston Road Suite 520 Dallas TX   75254
    (Address of principal executive offices)   (Zip Code)

     

    214-617-8250

    (Issuer’s telephone number)

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange
    on which registered
    Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant   LWACU   The Nasdaq Stock Market LLC
    Class A ordinary shares, par value $0.0001 per share   LWAC   The Nasdaq Stock Market LLC
    Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share   LWACW   The Nasdaq Stock Market LLC

     

    Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☐ No ☒

     

    Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer ☐ Accelerated filer ☐
    Non-accelerated filer ☒ Smaller reporting company ☒
        Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

    Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

     

    As of August 7, 2025, there were 22,168,750 Class A ordinary shares, $0.0001 par value and 7,906,250 Class B ordinary shares, $0.0001 par value, issued and outstanding. 

     

     

     

     

     

     

    LIGHTWAVE ACQUISITION CORP.

    FORM 10-Q FOR THE QUARTER ENDED MARCH 31, 2025 

     

    TABLE OF CONTENTS

     

        Page
    Part I. Financial Information   1
    Item 1. Interim Financial Statements   1
    Condensed Balance Sheet as of March 31, 2025 (Unaudited)   1
    Condensed Statement of Operations for the Period from January 22, 2025 (Inception) Through March 31, 2025 (Unaudited)   2
    Condensed Statement of Changes in Shareholder’s Deficit for the Period from January 22, 2025 (Inception) Through March 31, 2025 (Unaudited)   3
    Condensed Statement of Cash Flows for the Period from January 22, 2025 (Inception) Through March 31, 2025 (Unaudited)   4
    Notes to Condensed Financial Statements (Unaudited)   5
    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations   15
    Item 3. Quantitative and Qualitative Disclosures About Market Risk   17
    Item 4. Controls and Procedures   17
    Part II. Other Information   18
    Item 1. Legal Proceedings   18
    Item 1A. Risk Factors   18
    Item 2. Unregistered Sales of Equity Securities and Use of Proceeds   18
    Item 3. Defaults Upon Senior Securities   18
    Item 4. Mine Safety Disclosures   18
    Item 5. Other Information   18
    Item 6. Exhibits   19
    Part III. Signatures   20

     

    i

     

     

    PART I - FINANCIAL INFORMATION

     

    Item 1. Interim Financial Statements.

     

    LIGHTWAVE ACQUISITION CORP.

    CONDENSED BALANCE SHEET

    MARCH 31, 2025

    (UNAUDITED)

     

    Assets    
    Current assets    
    Cash  $14,591 
    Total current assets   14,591 
    Deferred offering costs   151,743 
    Total Assets  $166,334 
          
    Liabilities and Shareholders’ Deficit     
    Current Liabilities     
    Accrued offering costs  $126,743 
    Accounts payable and accrued expenses   36,777 
    Promissory note - related party   25,000 
    Total Current Liabilities   188,520 
          
    Commitments and Contingencies (Note 6)   
     
     
          
    Shareholders’ Deficit     
    Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding   
    —
     
    Class A ordinary shares, $0.0001 par value; 300,000,000 shares authorized; none issued or outstanding   
    —
     
    Class B ordinary shares, $0.0001 par value; 30,000,000 shares authorized; 7,906,250 shares issued and outstanding(1)(2)   791 
    Additional paid-in capital   24,209 
    Accumulated deficit   (47,186)
    Total Shareholders’ Deficit   (22,186)
    Total Liabilities and Shareholders’ Deficit  $166,334 

     

    (1) On March 7, 2025 and May 28, 2025, the Company, through a share capitalization, issued the Sponsor an additional 262,500 and 1,581,250 Class B ordinary shares, respectively, as a result of which the Sponsor has purchased and holds an aggregate of 7,906,250 Class B ordinary shares. All share and per share data have been retrospectively presented.
       
    (2) Includes an aggregate of up to 1,031,250 Class B ordinary shares subject to forfeiture by the holders thereof depending on the extent to which the underwriters’ over-allotment option was exercised (Note 5). On June 26, 2025, the Company consummated its Initial Public Offering and sold 21,562,500 Units, including 2,812,5000 Units sold pursuant to the full exercise of the underwriters’ option to purchase additional units to cover the over-allotment, hence the 1,031,250 Class B ordinary shares were no longer subject to forfeiture.

     

    The accompanying notes are an integral part of the unaudited condensed financial statements.

     

    1

     

     

    LIGHTWAVE ACQUISITION CORP.

    CONDENSED STATEMENT OF OPERATIONS

    FOR THE PERIOD FROM JANUARY 22, 2025 (INCEPTION) THROUGH MARCH 31, 2025

    (UNAUDITED)

     

    General and administrative expenses  $47,186 
    Loss from operations   (47,186)
          
    Net loss  $(47,186)
          
    Weighted average shares outstanding, Class B ordinary shares(1)(2)   6,875,000 
          
    Basic and diluted net loss per share, Class B ordinary shares  $(0.01)

     

    (1) On March 7, 2025 and May 28, 2025, the Company, through a share capitalization, issued the Sponsor an additional 262,500 and 1,581,250 Class B ordinary shares, respectively, as a result of which the Sponsor has purchased and holds an aggregate of 7,906,250 Class B ordinary shares. All share and per share data have been retrospectively presented.
       
    (2) Excludes up to 1,031,250 Class B ordinary shares subject to forfeiture by the holders thereof depending on the extent to which the underwriters’ over-allotment option was exercised (Note 5). On June 26, 2025, the Company consummated its Initial Public Offering and sold 21,562,500 Units, including 2,812,5000 Units sold pursuant to the full exercise of the underwriters’ option to purchase additional units to cover the over-allotment, hence the 1,031,250 Class B ordinary shares were no longer subject to forfeiture.

     

    The accompanying notes are an integral part of the unaudited condensed financial statements.

     

    2

     

     

    LIGHTWAVE ACQUISITION CORP.

    CONDENSED STATEMENT OF CHANGES IN SHAREHOLDER’S DEFICIT

    FOR THE PERIOD FROM JANUARY 22, 2025 (INCEPTION) THROUGH MARCH 31, 2025

    (UNAUDITED)

     

       Class A
    Ordinary Shares
       Class B
    Ordinary Shares
       Additional Paid-in   Accumulated   Total
    Shareholder’s
     
       Shares   Amount   Shares   Amount   Capital   Deficit   Deficit 
    Balance — January 22, 2025 (inception)   
    —
       $
    —
        
    —
       $
    —
       $
    —
       $
    —
       $
    —
     
                                        
    Issuance of Class B ordinary shares to Sponsor(1)(2)   
    —
        
    —
        7,906,250    791    24,209    
    —
        25,000 
                                        
    Net loss   —    —    —    —    —    (47,186)   (47,186)
                                        
    Balance – March 31, 2025 (unaudited)   
    —
       $
    —
        7,906,250   $791   $24,209   $(47,186)  $(22,186)

     

    (1) On March 7, 2025 and May 28, 2025, the Company, through a share capitalization, issued the Sponsor an additional 262,500 and 1,581,250 Class B ordinary shares, respectively, as a result of which the Sponsor has purchased and holds an aggregate of 7,906,250 Class B ordinary shares. All share and per share data have been retrospectively presented.
       
    (2) Includes an aggregate of up to 1,031,250 Class B ordinary shares subject to forfeiture by the holders thereof depending on the extent to which the underwriters’ over-allotment option was exercised (Note 5). On June 26, 2025, the Company consummated its Initial Public Offering and sold 21,562,500 Units, including 2,812,5000 Units sold pursuant to the full exercise of the underwriters’ option to purchase additional units to cover the over-allotment, hence the 1,031,250 Class B ordinary shares were no longer subject to forfeiture.

     

    The accompanying notes are an integral part of the unaudited condensed financial statements.

     

    3

     

     

     

    LIGHTWAVE ACQUISITION CORP.

    CONDENSED STATEMENT OF CASH FLOWS

    FOR THE PERIOD FROM JANUARY 22, 2025 (INCEPTION) THROUGH MARCH 31, 2025

    (UNAUDITED)

     

    Cash Flows from Operating Activities:    
    Net loss  $(47,186)
    Adjustments to reconcile net loss to net cash used in operating activities:     
    Changes in operating assets and liabilities:     
    Accrued expenses   36,777 
    Net cash used in operating activities   (10,409)
          
    Cash Flows from Financing Activities:     
    Proceeds from issuance of Class B ordinary shares   25,000 
    Net cash provided by financing activities   25,000 
          
    Net Change in Cash   14,591 
    Cash – Beginning of period   
    —
     
    Cash – End of period  $14,591 
          
    Supplemental disclosure of cash flow information:     
    Deferred offering costs included in accrued offering costs  $126,743 
    Deferred offering costs paid through promissory note - related party  $25,000 

     

    The accompanying notes are an integral part of the unaudited condensed financial statements. 

     

    4

     

     

    LIGHTWAVE ACQUISITION CORP.

    NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

    MARCH 31, 2025

    (Unaudited) 

     

    NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

     

    LightWave Acquisition Corp. (the “Company”) is a blank check company incorporated as a Cayman Islands exempted corporation on January 22, 2025. The Company was incorporated for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar Business Combination with one or more businesses (the “Business Combination”). The Company has not selected any specific Business Combination target and the Company has not, nor has anyone on its behalf, engaged in any substantive discussions, directly or indirectly, with any Business Combination target with respect to an initial Business Combination with the Company.

    As of March 31, 2025, the Company had not commenced any operations. All activity for the period from January 22, 2025 (inception) through March 31, 2025 relates to the Company’s formation, the initial public offering (“Initial Public Offering”), which is described below, and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering (as defined below). The Company has selected December 31 as its fiscal year end.

     

    The Company’s Sponsor is LightWave Founders LLC (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on June 24, 2025. On June 26, 2025, the Company consummated Initial Public Offering of 21,562,500 units at $10.00 per unit, which is discussed in Note 3, which includes the full exercise of the underwriters’ over-allotment option of 2,812,5000 Units, generating gross proceeds of $215,625,000.

     

    Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of an aggregate of 606,250 Private Placement Units (the “Private Placement Units”) to the Sponsor and the underwriters of the Initial Public Offering, at a price of $10.00 per unit, or $6,062,500 in the aggregate. Each Unit consists of one Class A ordinary share and one-half of one redeemable warrant. Of those 606,250 Private Placement Units, the Sponsor purchased 390,625 Private Placement Units and the underwriters in the Initial Public Offering purchased 215,625 private Placement Units. Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share.

     

    Transaction costs amounted to $12,386,896, consisting of $4,312,500 of cash underwriting fee, $7,546,875 of deferred underwriting fee, and $527,521 of other offering costs.

     

    The Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the net balance in the Trust Account (as defined below) (excluding the amount of deferred underwriting discounts held and taxes payable on the income earned on the Trust Account) at the time of the signing an agreement to enter into a Business Combination. However, the Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination.

     

    Upon the closing of the Initial Public Offering on June 26, 2025, an amount of $215,625,000 ($10.00 per Unit) from the net proceeds of the sale of the Units, and a portion of the proceeds of the sale of the Private Placement Units, are held in a Trust Account (the “Trust Account”) and will only be invested in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act, which invest only in direct U.S. government treasury obligations; the holding of these assets in this form is intended to be temporary and for the sole purpose of facilitating the intended business combination. To mitigate the risk that might be deemed to be an investment company for purposes of the Investment Company Act, which risk increases the longer that the Company holds investments in the Trust Account, the Company may, at any time (based on management team’s ongoing assessment of all factors related to the potential status under the Investment Company Act), instruct the trustee to liquidate the investments held in the Trust Account and instead to hold the funds in the Trust Account in cash or in an interest bearing demand deposit account at a bank. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its taxes, if any, the proceeds from the Initial Public Offering and the sale of the Private Placement Units will not be released from the Trust Account until the earliest of (i) the completion of the Company’s initial Business Combination, (ii) the redemption of the Company’s public shares if the Company is unable to complete the initial Business Combination within 24 months from the closing of the Initial Public Offering or by such earlier liquidation date as our board of directors may approve (the “Completion Window”), subject to applicable law, or (iii) the redemption of the Company’s public shares properly submitted in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association to (A) modify the substance or timing of the Company’s obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the Company’s public shares if the Company has not consummated an initial Business Combination within the Completion Window or (B) with respect to any other material provisions relating to shareholders’ rights or pre-initial Business Combination activity. The proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the Company’s public shareholders.

     

    The Company will provide the Company’s public shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business Combination either (i) in connection with a general meeting called to approve the initial Business Combination or (ii) without a shareholder vote by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed initial Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public shareholders will be entitled to redeem their shares at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation of the initial Business Combination, including interest earned on the funds held in the Trust Account (less taxes payable), divided by the number of then outstanding public shares, subject to the limitations. The amount in the Trust Account is initially anticipated to be $10.00 per public share.

    5

     

     

    LIGHTWAVE ACQUISITION CORP.

    NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

    MARCH 31, 2025

    (Unaudited) 

     

    The ordinary shares subject to redemption were recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.”

     

    The Company will have only the duration of the Completion Window to complete the initial Business Combination. However, if the Company is unable to complete its initial Business Combination within the Completion Window, the Company will as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account (less taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will constitute full and complete payment for the public shares and completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation or other distributions, if any), subject to the Company’s obligations under Cayman Islands law to provide for claims of creditors and subject to the other requirements of applicable law.

     

    The Sponsor, officers and directors have entered into a letter agreement with the Company, pursuant to which they have agreed to (i) waive their redemption rights with respect to their founder shares, private shares and public shares in connection with the completion of the initial Business Combination or an earlier redemption in connection with the commencement of the procedures to consummate the initial Business Combination if the Company determines it is desirable to facilitate the completion of the initial Business Combination; (ii) waive their redemption rights with respect to their founder shares, private shares and public shares in connection with a shareholder vote to approve an amendment to the Company’s amended and restated memorandum and articles of association; (iii) waive their rights to liquidating distributions from the Trust Account with respect to their founder shares and private shares if the Company fails to complete the initial Business Combination within the Completion Window, although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete the initial Business Combination within the Completion Window and to liquidating distributions from assets outside the Trust Account; and (iv) vote any founder shares held by them and any public shares purchased during or after the Initial Public Offering (including in open market and privately-negotiated transactions) in favor of the initial Business Combination.


    The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and the Company believes that the Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure that the Sponsor would be able to satisfy those obligations.

     

    NOTE 2. SIGNIFICANT ACCOUNTING POLICIES

     

    Basis of Presentation

     

    The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the U.S. Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in unaudited condensed financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the period presented.

     

    The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s prospectus for its Initial Public Offering as filed with the SEC on June 26, 2025, as well as the Company’s Current Report on Form 8-K, as filed with the SEC on July 2, 2025. The interim results for the period from January 22, 2025 (inception) through March 31, 2025 are not necessarily indicative of the results to be expected for the year ending December 31, 2025 or for any future periods.

     

    6

     

     

    LIGHTWAVE ACQUISITION CORP.

    NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

    MARCH 31, 2025

    (Unaudited) 

     

    Liquidity and Capital Resources

     

    The Company’s liquidity needs up to March 31, 2025 had been satisfied through the loan under an unsecured promissory note and advances from related party. At March 31, 2025, the Company had cash of $14,591 and working capital deficit of $173,929. Prior to the completion of the Initial Public Offering, the Company lacked the liquidity it needed to sustain operations for a reasonable period of time, which is considered to be one year from the issuance date of the unaudited condensed financial statements. The Company has since completed its Initial Public Offering at which time capital in excess of the funds deposited in the Trust Account and/or used to fund offering expenses will be available to the Company for general working capital purposes.

     

    In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans. In the event that a Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital Loans may be convertible into private placement units of the post Business Combination entity at a price of $10.00 per unit at the option of the lender. As of March 31, 2025, no such Working Capital Loans were outstanding.

     

    In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Codification (“ASC”) 205-40, “Presentation of Financial Statements- Going Concern,” and through the consummation of the Initial Public Offering, the Company has sufficient funds for the working capital needs of the Company until a minimum of one year from the date of issuance of these unaudited condensed financial statements. The Company does not believe it will need to raise additional funds in order to meet the expenditures required for operating its business following the consummation of the Company's Initial Public Offering. However, if the estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination are less than the actual amount necessary to do so, the Company may have insufficient funds available to operate its business prior to the initial Business Combination. Management has determined that the Company has sufficient funds to finance the working capital needs of the Company within one year from the date of issuance of the unaudited condensed financial statements.

     

    Emerging Growth Company Status

     

    The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

     

    Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

     

    Use of Estimates

     

    The preparation of the unaudited condensed financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of revenues and expenses during the reporting period.

     

    Making estimates requires management to exercise significant judgement. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

      

    Cash

     

    The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $14,591 in cash and no cash equivalents of as of March 31, 2025.

     

    7

     

     

    LIGHTWAVE ACQUISITION CORP.

    NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

    MARCH 31, 2025

    (Unaudited) 

     

    Concentration of Credit Risk

     

    Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.

     

    Deferred Offering Costs

     

    The Company complies with the requirements of the ASC 340-10-S99 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A — “Expenses of Offering.” Deferred offering costs consist principally of professional and registration fees that are related to the Proposed Public Offering. Financial Accounting Standards Board (“FASB”) ASC 470-20, “Debt with Conversion and Other Options,” addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applies this guidance to allocate Proposed Public Offering proceeds from the Public Units between Class A ordinary shares and warrants, using the residual method by allocating Proposed Public Offering proceeds first to assigned value of the warrants and then to the Class A ordinary shares. Offering costs allocated to the Class A ordinary shares subject to possible redemption were charged to temporary equity, and offering costs allocated to the warrants included in the Public Units and Private Placement Units were charged to shareholder’s equity as the warrants, after management’s evaluation, are accounted for under equity treatment at the closing of the Initial Public Offering.

     

    Fair Value of Financial Instruments

     

    The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet, primarily due to its short-term nature.


    Income Taxes

     

    The Company accounts for income taxes under ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statements and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

     

    ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statements recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of March 31, 2025, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

     

    The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the period presented.

    Warrant Instruments

     

    The Company accounts for the Warrants issued in connection with the Initial Public Offering and the private placement in accordance with the guidance contained in FASB ASC Topic 815, “Derivatives and Hedging”. Accordingly, the Company evaluated and classified the warrant instruments under equity treatment at their assigned values. There were no Public Warrants or Private Placement Warrants outstanding as of March 31, 2025.

     

    8

     

     

    LIGHTWAVE ACQUISITION CORP.

    NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

    MARCH 31, 2025

    (Unaudited) 

     

    Net Loss per Ordinary Share

     

    Net loss per ordinary share is computed by dividing net loss by the weighted average number of ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of 1,031,250 ordinary shares that would have been subject to forfeiture had the over-allotment option not been exercised by the underwriters (see Note 7). At March 31, 2025, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted loss per ordinary share is the same as basic loss per ordinary share for the period presented.

     

    Recent Accounting Pronouncements

     

    In November 2023, the FASB issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures”. The amendments in this ASU require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating decision maker (“CODM”), as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. The ASU requires that a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. Public entities will be required to provide all annual disclosures currently required by Topic 280 in interim periods, and entities with a single reportable segment are required to provide all the disclosures required by the amendments in this ASU and existing segment disclosures in Topic 280. This ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company adopted ASU 2023-07 on January 22, 2025, date of inception.

     

    Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

     

    Note 3 — Initial Public Offering

     

    Pursuant to the Initial Public Offering on June 26, 2025, the Company sold 21,562,500 Units at a purchase price of $10.00 per Unit for a total of $215,625,000, which includes the full exercise of the underwriters’ overallotment option in the amount of 2,812,500 Units. Each Unit consists of one Class A ordinary share, and one-half of one redeemable warrant. Each whole warrant will entitle the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment. Each warrant will become exercisable 30 days after the completion of the initial Business Combination and will expire five years after the completion of the initial Business Combination, or earlier upon redemption or liquidation.


    Note 4 — Private Placement

     

    Simultaneously with the closing of the Initial Public Offering, the Sponsor and the underwriters in the Initial Public Offering purchased an aggregate of 606,250 Private Placement Units, consisting of one Class A ordinary share and one half warrant in which each whole warrant is exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $10.00 per unit, or $6,062,500 in the aggregate. Of those 606,250 Private Placement Units, the Sponsor purchased 390,625 Private Placement Units and the underwriters in the Initial Public Offering purchased 215,625 Private Placement Units. Each whole warrant entitles the registered holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment.

     

    The Private Placement Units are identical to the Public Units sold in the Initial Public Offering except that, so long as they are held by the Sponsor, the underwriters or their permitted transferees, the Private Placement Units (i) may not (including the Class A ordinary shares issuable upon exercise of the warrants contained in the Private Placement Units), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of the initial Business Combination, (ii) will be entitled to registration rights and (iii) with respect to private placement units contained in the Private Placement Units held by the underwriters and/or their designees, will not be exercisable more than five years from the commencement of sales in the Initial Public Offering in accordance with FINRA Rule 5110(g)(8).

     

    The Sponsor and the Company’s officers and directors have entered into a letter agreement with the Company, pursuant to which they have agreed to (i) waive their redemption rights with respect to their founder shares, private shares and public shares in connection with the completion of the initial Business Combination or an earlier redemption in connection with the commencement of the procedures to consummate the initial Business Combination if the Company determines it is desirable to facilitate the completion of the initial Business Combination; (ii) waive their redemption rights with respect to their founder shares, private shares and public shares in connection with a shareholder vote to approve an amendment to the Company’s amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the public shares if the Company has not consummated an initial Business Combination within the Completion Window or (B) with respect to any other material provisions relating to shareholders’ rights or pre-initial Business Combination activity; (iii) waive their rights to liquidating distributions from the Trust Account with respect to their founder shares and private shares if the Company fails to complete the initial Business Combination within the Completion Window, although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete the initial Business Combination within the Completion Window and to liquidating distributions from assets outside the Trust Account; and (iv) vote any founder shares held by them and any public shares purchased during or after the Initial Public Offering (including in open market and privately-negotiated transactions) in favor of the initial Business Combination.

     

    9

     

     

    LIGHTWAVE ACQUISITION CORP.

    NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

    MARCH 31, 2025

    (Unaudited) 

     

    Note 5 — Related Party Transactions

     

    Founder Shares

     

    On January 29, 2025, the Company issued an aggregate of 6,062,500 Class B ordinary shares, $0.0001 par value (the “Founder Shares”), in exchange for a $25,000 payment (approximately $0.003 per share) from the Sponsor to cover certain expenses on behalf of the Company. On March 7, 2025, the Company issued a share recapitalization for 262,500 ordinary shares to the Sponsor, whereby the Sponsor held 6,325,000 Class B ordinary shares. On May 28, 2025, the Company issued a share recapitalization for 1,581,250 ordinary shares to the Sponsor, whereby the Sponsor now holds 7,906,250 Class B ordinary shares. Up to 1,031,250 of the Founder Shares may be surrendered by the Sponsor for no consideration depending on the extent to which the underwriters’ over-allotment is exercised. On June 26, 2025, the underwriters exercised their over-allotment option in full as part of the closing of the Initial Public Offering. As such, the 1,031,250 founder shares are no longer subject to forfeiture.

     

    The Company’s initial shareholders have agreed not to transfer, assign or sell any of their founder shares and any Class A ordinary shares issued upon conversion thereof until the earlier to occur of (i) six months after the completion of the initial Business Combination or (ii) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction after the initial Business Combination that results in all of the Company’s shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property. Any permitted transferees will be subject to the same restrictions and other agreements of the Company’s initial shareholders with respect to any founder shares (the “Lock-up”). Notwithstanding the foregoing, if (1) the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 30 days after our initial Business Combination or (2) if the Company consummates a transaction after the initial Business Combination which results in the Company’s shareholders having the right to exchange their shares for cash, securities or other property, the founder shares will be released from the Lock-up.

     

    Promissory Note — Related Party

     

    The Sponsor had agreed to loan the Company an aggregate of up to $25,000 to be used for a portion of the expenses of the Initial Public Offering. The loan is non-interest bearing, unsecured and due at the earlier of the closing date of the Initial Public Offering or the date on which the Company determines not to conduct an initial public offering. The loan will be repaid out of the $650,000 of offering proceeds that has been allocated to the payment of offering expenses. As of March 31, 2025, the Company had borrowed $25,000 under the promissory note. At the closing of the Initial Public Offering, on June 26, 2025, the Company repaid the outstanding balance. Borrowings under the note are no longer available.
     

    Administrative Services Agreement

     

    Commencing on June 24, 2025, the Company entered into an agreement with the Sponsor or an affiliate to pay an aggregate of $10,000 per month for office space, utilities and secretarial and administrative support. These monthly fees will cease upon the completion of the initial Business Combination or the liquidation of the Company. For the period from January 22, 2025 (inception) through March 31, 2025, the Company did not incur any in fees for these services.

    Working Capital Loans

     

    In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans. In the event that a Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital Loans may be convertible into private placement units of the post Business Combination entity at a price of $10.00 per unit at the option of the lender. As of March 31, 2025, no such Working Capital Loans were outstanding.

     

    10

     

     

    LIGHTWAVE ACQUISITION CORP.

    NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

    MARCH 31, 2025

    (Unaudited) 

    Note 6 — Commitments and Contingencies

     

    Risks and Uncertainties

     

    The United States and global markets are experiencing volatility and disruption following the geopolitical instability resulting from the ongoing Russia-Ukraine conflict and the Israel-Hamas conflict. In response to the ongoing Russia-Ukraine conflict, the North Atlantic Treaty Organization (“NATO”) deployed additional military forces to eastern Europe, and the United States, the United Kingdom, the European Union and other countries have announced various sanctions and restrictive actions against Russia, Belarus and related individuals and entities, including the removal of certain financial institutions from the Society for Worldwide Interbank Financial Telecommunication payment system. Certain countries, including the United States, have also provided and may continue to provide military aid or other assistance to Ukraine and to Israel, increasing geopolitical tensions among a number of nations. The invasion of Ukraine by Russia and the Israel-Hamas conflict and the resulting measures that have been taken, and could be taken in the future, by NATO, the United States, the United Kingdom, the European Union, Israel and its neighboring states and other countries have created global security concerns that could have a lasting impact on regional and global economies. Although the length and impact of the ongoing conflicts are highly unpredictable, they could lead to market disruptions, including significant volatility in commodity prices, credit and capital markets, as well as supply chain interruptions and increased cyberattacks against U.S. companies. Additionally, any resulting sanctions could adversely affect the global economy and financial markets and lead to instability and lack of liquidity in capital markets.

     

    Any of the above-mentioned factors, or any other negative impact on the global economy, capital markets or other geopolitical conditions resulting from the Russian invasion of Ukraine, the escalation of the Israel-Hamas conflict and subsequent sanctions or related actions, could adversely affect the Company’s search for an initial Business Combination and any target business with which the Company may ultimately consummate an initial Business Combination.

     

    Registration Rights

     

    The holders of the founder shares, Private Placement Units and the Class A ordinary shares underlying the warrants contained in such Private Placement Units and Units that may be issued upon conversion of the Working Capital Loans have registration rights to require the Company to register for resale of any of the Company’s securities held by them and any other securities of the Company acquired by them prior to the consummation of the initial Business Combination pursuant to a registration rights agreement signed prior to the effective date of the Initial Public Offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain piggyback registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. Notwithstanding anything to the contrary, the underwriters may only make a demand on one occasion and only during the five-year period beginning on the effective date of the Initial Public Offering. In addition, the underwriters may participate in a piggyback registration only during the seven-year period beginning on the effective date of the Initial Public Offering. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

     

    Underwriters’ Agreement

     

    The underwriters had a 45-day option from the date of the Initial Public Offering to purchase up to an additional 2,812,500 units to cover over-allotments, if any. On June 26, 2025, simultaneously with the closing of the Initial Public Offering, the underwriters elected to fully exercise the over-allotment option to purchase the additional 2,812,500 Units at a price of $10.00 per Unit.

     

    The underwriters were entitled to a cash underwriting discount of $0.20 per Unit, or $4,312,500 in the aggregate (the “Base Fee”), which was paid to the underwriters at the closing of the Initial Public Offering. Additionally, the underwriters are entitled to a deferred underwriting discount of $0.35 per Unit, or $7,546,875 in the aggregate, payable to the representative on behalf of the underwriters only upon the consummation of an initial Business Combination. The deferred underwriting commissions will be payable to the representative on behalf of the underwriters upon the closing of the initial Business Combination in three portions, as follows: (i) $0.25 per unit sold in the Initial Public Offering shall be paid to the underwriters in cash, (ii) up to $0.05 per unit sold in the Initial Public Offering shall be paid to the underwriters in cash, based on the funds remaining in the Trust Account after giving effect to Class A ordinary shares that are redeemed in connection with an initial Business Combination and (iii) $0.05 per unit sold in the Initial Public Offering shall be paid to the underwriters in cash (such aggregate amount, the “Allocable Amount”), provided that, after completion of the Initial Public Offering and the underwriters’ receipt of 100% of the Base Fee, the Company has the right, in its sole discretion, not to pay all or any portion of the Allocable Amount to the representative and to use the Allocable Amount for expenses in connection with the initial Business Combination.

     

    Note 7 — Shareholder’s Deficit

     

    Preference Shares — The Company is authorized to issue a total of 1,000,000 preference shares at par value of $0.0001. At March 31, 2025, there were no preference shares issued or outstanding.

     

    Class A Ordinary Shares — The Company is authorized to issue a total of 300,000,000 Class A ordinary shares at par value of $0.0001 per share. At March 31, 2025, there were no shares Class A ordinary shares issued or outstanding.

     

    11

     

     

    LIGHTWAVE ACQUISITION CORP.

    NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

    MARCH 31, 2025

    (Unaudited) 

     

    Class B Ordinary Shares — The Company is authorized to issue a total of 30,000,000 Class B ordinary shares at par value of $0.0001 per share. On January 29, 2025, the Company issued an aggregate of 6,062,500 Class B ordinary shares, $0.0001 par value (the “Founder Shares”), in exchange for a $25,000 payment (approximately $0.003 per share) from the Sponsor to cover certain expenses on behalf of the Company. In March 2025, the Company issued a share capitalization for 262,500 ordinary shares to the Sponsor, whereby the Sponsor now held 6,325,000 Class B ordinary shares. In May 2025, the Company issued a share capitalization for 1,581,250 ordinary shares to the Sponsor, whereby the Sponsor now holds 7,906,250 Class B ordinary shares. The Founder Shares included an aggregate of up to 1,031,250 shares subject to forfeiture if the over-allotment option is not exercised by the underwriters in full. On June 26, 2025, the underwriters exercised their over-allotment option in full as part of the closing of the Initial Public Offering. As such, the 1,031,250 founder shares are no longer subject to forfeiture.

     

    The Founder Shares will automatically convert into Class A ordinary shares concurrently with or immediately following the consummation of the initial Business Combination or earlier at the option of the holder on a one-for-one basis, subject to adjustment for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional Class A ordinary shares, or any other equity-linked securities, are issued or deemed issued in excess of the amounts sold in the Initial Public Offering and related to or in connection with the closing of the initial Business Combination, the ratio at which Class B ordinary shares convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the outstanding Class B ordinary shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, approximately 26.8% of the sum of (i) the total number of all Class A ordinary shares outstanding upon the completion of the Initial Public Offering (including any Class A ordinary shares issued pursuant to the underwriters’ over-allotment option and excluding the Class A ordinary shares underlying the warrants contained in the private placement units), plus (ii) all Class A ordinary shares and equity-linked securities issued or deemed issued, in connection with the closing of the initial Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial Business Combination and any private placement-equivalent warrants issued to our sponsor or any of its affiliates or to our officers or directors upon conversion of working capital loans) minus (iii) any redemptions of Class A ordinary shares by public shareholders in connection with an initial Business Combination; provided that such conversion of founder shares will never occur on a less than one-for-one basis.

     

    Holders of record of the Company’s Class A ordinary shares and Class B ordinary shares are entitled to one vote for each share held on all matters to be voted on by shareholders. Unless specified in the amended and restated memorandum and articles of association or as required by the Companies Act or stock exchange rules, an ordinary resolution under Cayman Islands law and the amended and restated memorandum and articles of association, which requires the affirmative vote of at least a majority of the votes cast by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting of the Company is generally required to approve any matter voted on by our shareholders. Approval of certain actions requires a special resolution under Cayman Islands law, which (except as specified below) requires the affirmative vote of at least two-thirds of the votes cast by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting, and pursuant to the amended and restated memorandum and articles of association, such actions include amending our amended and restated memorandum and articles of association and approving a statutory merger or consolidation with another company. There is no cumulative voting with respect to the appointment of directors, meaning, following our initial Business Combination, the holders of more than 50% of the ordinary shares voted for the appointment of directors can elect all of the directors. Prior to the consummation of the initial Business Combination, only holders of the Class B ordinary shares will (i) have the right to vote on the appointment and removal of directors and (ii) be entitled to vote on continuing our company in a jurisdiction outside the Cayman Islands (including any special resolution required to amend the constitutional documents or to adopt new constitutional documents, in each case, as a result of our approving a transfer by way of continuation in a jurisdiction outside the Cayman Islands). Holders of the Class A ordinary shares will not be entitled to vote on these matters during such time. These provisions of the amended and restated memorandum and articles of association may only be amended if approved by a special resolution passed by the affirmative vote of at least 90% (or, where such amendment is proposed in respect of the consummation of the initial Business Combination, two-thirds) of the votes cast by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting of the Company.

     

    Warrants — As of March 31, 2025, there were no Public and Private Placement Warrants outstanding. Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment as discussed herein. The warrants cannot be exercised until 30 days after the completion of the initial Business Combination, and will expire at 5:00 p.m., New York City time, five years after the completion of the initial Business Combination or earlier upon redemption or liquidation.

     

    The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the Class A ordinary shares underlying the warrants is then effective and a prospectus relating thereto is current. No warrant will be exercisable and the Company will not be obligated to issue a Class A ordinary share upon exercise of a warrant unless the Class A ordinary share issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a warrant, the holder of such warrant will not be entitled to exercise such warrant and such warrant may have no value and expire worthless. In no event will the Company be required to net cash settle any warrant. In the event that a registration statement is not effective for the exercised warrants, the purchaser of a unit containing such warrant will have paid the full purchase price for the unit solely for the Class A ordinary share underlying such unit.

     

    12

     

     

    LIGHTWAVE ACQUISITION CORP.

    NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

    MARCH 31, 2025

    (Unaudited) 

     

    Under the terms of the warrant agreement, the Company has agreed that, as soon as practicable, but in no event later than 20 business days, after the closing of its Business Combination, it will use its commercially reasonable efforts to file with the SEC a post-effective amendment to the registration statement for the Initial Public Offering or a new registration statement covering the registration under the Securities Act of the Class A ordinary shares issuable upon exercise of the warrants and thereafter will use its commercially reasonable efforts to cause the same to become effective within 60 business days following the Company’s initial Business Combination and to maintain a current prospectus relating to the Class A ordinary shares issuable upon exercise of the warrants until the expiration of the warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the sixtieth (60th) business day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of public warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, the Company will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.

     

    If the holders exercise their public warrants on a cashless basis, they would pay the warrant exercise price by surrendering the warrants for that number of Class A ordinary shares equal to the quotient obtained by dividing (x) the product of the number of Class A ordinary shares underlying the warrants, multiplied by the excess of the “fair market value” of the Class A ordinary shares over the exercise price of the warrants by (y) the fair market value. The “fair market value” is the average reported closing price of the Class A ordinary shares for the 10 trading days ending on the third trading day prior to the date on which the notice of exercise is received by the warrant agent or on which the notice of redemption is sent to the holders of warrants, as applicable.

     

    Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00:    The Company may redeem the outstanding warrants: 

     

      ● in whole and not in part;

     

      ● at a price of $0.01 per warrant;

     

      ● upon a minimum of 30 days’ prior written notice of redemption (the “30-day redemption period”); and

     

      ● if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant) for any 20 trading days within a 30-trading day period commencing at least 30 days after completion of our initial Business Combination and ending three business days before we send the notice of redemption to the warrant holders.

     

    Additionally, if the number of outstanding Class A ordinary shares is increased by a share capitalization payable in Class A ordinary shares, or by a sub-division of ordinary shares or other similar event, then, on the effective date of such share capitalization, sub-division or similar event, the number of Class A ordinary shares issuable on exercise of each warrant will be increased in proportion to such increase in the outstanding ordinary shares. A rights offering made to all or substantially all holders of ordinary shares entitling holders to purchase Class A ordinary shares at a price less than the fair market value will be deemed a share capitalization of a number of Class A ordinary shares equal to the product of (i) the number of Class A ordinary shares actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are convertible into or exercisable for Class A ordinary shares) and (ii) the quotient of (x) the price per Class A ordinary share paid in such rights offering and (y) the fair market value. For these purposes (i) if the rights offering is for securities convertible into or exercisable for Class A ordinary shares, in determining the price payable for Class A ordinary shares, there will be taken into account any consideration received for such rights, as well as any additional amount payable upon exercise or conversion and (ii) fair market value means the volume weighted average price of Class A ordinary shares as reported during the ten (10) trading day period ending on the trading day prior to the first date on which the Class A ordinary shares trade on the applicable exchange or in the applicable market, regular way, without the right to receive such rights.

     

    Note 8 — Segment Information

     

    ASC Topic 280, “Segment Reporting,” establishes standards for companies to report in their financial statement information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise for which separate financial information is available that is regularly evaluated by the Company’s chief operating decision maker, or group, in deciding how to allocate resources and assess performance.

     

    13

     

     

    LIGHTWAVE ACQUISITION CORP.

    NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

    MARCH 31, 2025

    (Unaudited) 

     

    The Company’s chief operating decision maker (“CODM”) has been identified as the Chief Executive Officer, who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has one reportable segment.

     

    The CODM assesses performance for the single segment and decides how to allocate resources based on net income or loss that also is reported on the statement of operations as net income or loss. The measure of segment assets is reported on the balance sheet as total assets.

     

    When evaluating the Company’s performance and making key decisions regarding resource allocation the CODM reviews several key metrics, which include the following:

     

       March 31,
    2025
     
    Cash  $14,591 
    Deferred offering costs  $151,743 

     

     

       For the
    Period from
    January 22,
    2025
    (Inception)
    Through
    March 31,
    2025
     
    General and administrative expenses  $47,186 

     

    General and administrative costs are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a Business Combination or similar transaction within the Business Combination period. The CODM also reviews general and administrative costs to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget. General and administrative costs are the significant segment expenses provided to the CODM on a regular basis.

     

    Note 9 — Subsequent Events

     

    The Company evaluated subsequent events and transactions that occurred after the unaudited condensed balance sheet date through August 7, 2025, the date that the unaudited condensed financial statements were available to be issued. Based upon this review, other than as noted below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.

     

    In May 2025, the Sponsor granted membership interests equivalent to an aggregate of 300,000 founder shares to the members of the Company in exchange for their services as the officer and independent directors through the Company’s initial Business Combination. The founder shares, represented by such membership interests, will remain with the Sponsor if the holder of such membership interests are no longer serving the Company prior to the initial Business Combination. The membership interest assignment of the founder shares to the holders of such interests are in the scope of FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the assignment date. The total fair value of the 300,000 founder shares represented by such membership interests assigned to the holders of such interests on June 26, 2025 was $372,000 or $1.24 per share. The Company established the initial fair value founder shares on May 9, 2025, the date of the grant agreement, using a calculation prepared by a third party valuation team which takes into consideration the market adjustment of 12.5%, a risk free rate of 4.28% and a stock price of $9.86. The founder shares are classified as Level 3 at the measurement date due to the use of unobservable inputs, and other risk factors.

     

    Commencing on June 24, 2025, the Company entered into an agreement with the Sponsor or an affiliate to pay an aggregate of $10,000 per month for office space, utilities and secretarial and administrative support. These monthly fees will cease upon the completion of the initial Business Combination or the liquidation of the Company.

     

    On June 26, 2025, the Company consummated Initial Public Offering of 21,562,500 units at $10.00 per unit, which is discussed in Note 3, which includes the full exercise of the underwriters’ over-allotment option of 2,812,5000 Units, generating gross proceeds of $215,625,000.

     

    Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of an aggregate of 606,250 Private Placement Units  to the Sponsor and the underwriters of the Initial Public Offering, at a price of $10.00 per unit, or $6,062,500 in the aggregate. Each Unit consists of one Class A ordinary share and one-half of one redeemable warrant. Of those 606,250 Private Placement Units, the Sponsor purchased 390,625 Private Placement Units and the underwriters in the Initial Public Offering purchased 215,625 private Placement Units. Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share.

     

    On June 26, 2025, the Company repaid in excess of the promissory note – related party of $25,000 and advances from related party of $144,500, to the Sponsor, a total $130,500. The $130,500 is due to be repaid to the Company from the Sponsor. Subsequently, on July 7, 2025, the Sponsor repaid $105,500 of the amount due to the Company and $25,000 remains outstanding.

     

    14

     

     

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

     

    References in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to LightWave Acquisition Corp. References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to LightWave Founders LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

     

    Special Note Regarding Forward-Looking Statements

     

    This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Form 10-Q including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the completion of the Proposed Business Combination (as defined below), the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements, including that the conditions of the Proposed Business Combination are not satisfied. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s final prospectus for its Initial Public Offering filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

     

    Overview

     

    We are a blank check company incorporated in the Cayman Islands on January 22, 2025 formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar Business Combination with one or more businesses (the “Business Combination”). We intend to effectuate our Business Combination using cash derived from the proceeds of the Initial Public Offering and the sale of the Private Placement Units, our shares, debt or a combination of cash, shares and debt.

     

    We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.

     

    Results of Operations

     

    We have neither engaged in any operations nor generated any revenues to date. Our only activities from January 22, 2025 (inception) through March 31, 2025 were organizational activities, those necessary to prepare for the Initial Public Offering, described below, and identifying a target company for a Business Combination. We do not expect to generate any operating revenues until after the completion of our Business Combination. Subsequent to the Initial Public Offering, we generate non-operating income in the form of interest income on marketable securities held in the Trust Account. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.

     

    For the period from January 22, 2025 (inception) through March 31, 2025, we had a net loss $47,186, which consisted of general and administrative expenses.

     

    Liquidity and Capital Resources

     

    Until the consummation of the Initial Public Offering, our only source of liquidity was an initial purchase of shares of Class B ordinary shares, par value $0.0001 per share, by the Sponsor and loans from the Sponsor.

     

    Subsequent to the quarterly period covered by this Quarterly Report on Form 10-Q, On June 26, 2025, we consummated Initial Public Offering of 21,562,500 Units at $10.00 per Unit, which is discussed in Note 3, which includes the full exercise of the underwriters’ over-allotment option of 2,812,5000 Units, generating gross proceeds of $215,625,000. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of an aggregate of 606,250 Private Placement Units to the Sponsor and the underwriters of the Initial Public Offering, at a price of $10.00 per unit, or $6,062,500 in the aggregate.

     

    15

     

     

    Following the Initial Public Offering, the full exercise of the over-allotment option, and the sale of the Units, a total of $215,625,000 was placed in the Trust Account. We incurred $12,386,896, consisting of $4,312,500 of cash underwriting fee, $7,546,875 of deferred underwriting fee, and $527,521 of other offering costs.

     

    We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less income taxes payable), to complete our Business Combination. To the extent that our share capital or debt is used, in whole or in part, as consideration to complete our Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.  

     

    We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.

     

    In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor, or certain of our officers and directors or their affiliates may, but are not obligated to, loan us funds as may be required. If we complete a Business Combination, we would repay such loaned amounts. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of such Working Capital Loans may be convertible into private placement units of the post Business Combination entity at a price of $10.00 per unit at the option of the lender.

     

    We do not believe we will need to raise additional funds in order to meet the expenditures required for operating our business. However, if our estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our Business Combination. Moreover, we may need to obtain additional financing either to complete our Business Combination or because we become obligated to redeem a significant number of our Public Shares upon consummation of our Business Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination.

     

    Off-Balance Sheet Arrangements

     

    We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of March 31, 2025. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

     

    Contractual obligations

      

    We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement with the Sponsor or an affiliate to pay an aggregate of $10,000 per month for office space, utilities and secretarial and administrative support. These monthly fees will cease upon the completion of the initial Business Combination or the liquidation of the Company.

     

    The underwriters had a 45-day option from the date of the Initial Public Offering to purchase up to an additional 2,812,500 units to cover over-allotments, if any. On June 26, 2025, simultaneously with the closing of the Initial Public Offering, the underwriters elected to fully exercise the over-allotment option to purchase the additional 2,812,500 Units at a price of $10.00 per Unit.

     

    The underwriters were entitled to a cash underwriting discount of $0.20 per Unit, or $4,312,500 in the aggregate (the “Base Fee”), which was paid to the underwriters at the closing of the Initial Public Offering. Additionally, the underwriters are entitled to a deferred underwriting discount of $0.35 per Unit, or $7,546,875 in the aggregate, payable to the representative on behalf of the underwriters only upon the consummation of an initial Business Combination. The deferred underwriting commissions will be payable to the representative on behalf of the underwriters upon the closing of the initial Business Combination in three portions, as follows: (i) $0.25 per unit sold in the Initial Public Offering shall be paid to the underwriters in cash, (ii) up to $0.05 per unit sold in the Initial Public Offering shall be paid to the underwriters in cash, based on the funds remaining in the Trust Account after giving effect to Class A ordinary shares that are redeemed in connection with an initial Business Combination and (iii) $0.05 per unit sold in the Initial Public Offering shall be paid to the underwriters in cash (such aggregate amount, the “Allocable Amount”), provided that, after completion of the Initial Public Offering and the underwriters’ receipt of 100% of the Base Fee, the Company has the right, in its sole discretion, not to pay all or any portion of the Allocable Amount to the representative and to use the Allocable Amount for expenses in connection with the initial Business Combination.

     

    Critical Accounting Estimates

     

    The preparation of unaudited condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Making estimates requires management to exercise significant judgement. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could materially differ from those estimates. As of March 31, 2025, we did not have any critical accounting estimates to be disclosed.

     

    16

     

     

    Item 3. Quantitative and Qualitative Disclosures About Market Risk

     

    Not required for smaller reporting companies.

      

    Item 4. Controls and Procedures

     

    Evaluation of Disclosure Controls and Procedures

     

    Disclosure controls and procedures are controls and other procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to Management, including our Chief Executive Officer and Chief Financial Officer (together, the “Certifying Officers”), or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.

     

    Under the supervision and with the participation of our Management, including our Certifying Officers, we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on the foregoing, our Certifying Officers concluded that our disclosure controls and procedures were effective as of the end of the quarterly period ended March 31, 2025.

     

    Changes in Internal Control over Financial Reporting

     

    There was no change in our internal control over financial reporting that occurred during the fiscal quarter of 2025 covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

     

    17

     

     

    PART II - OTHER INFORMATION

     

    Item 1. Legal Proceedings

     

    None

     

    Item 1A. Risk Factors

     

    Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

     

    Item 3. Defaults Upon Senior Securities

     

    None

     

    Item 4. Mine Safety Disclosures

     

    None

     

    Item 5. Other Information

     

    None

     

    18

     

     

    Item 6. Exhibits

     

    The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

      

    No.   Description of Exhibit
    31.1*   Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
    31.2*   Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
    32.1**   Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
    32.2**   Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
    101.INS   Inline XBRL Instance Document.
    101.SCH   Inline XBRL Taxonomy Extension Schema Document.
    101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document.
    101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document.
    101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document.
    101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document.
    104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

     

    * Filed herewith.

     

    ** These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

     

    19

     

     

    SIGNATURES

     

    In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

      LIGHTWAVE ACQUISITION CORP.
         
    Date: August 8, 2025 By: /s/ Robert Bennett
      Name:  Robert Bennett
      Title: Chairman and Chief Executive Officer
        (principal executive officer)
         
    Date: August 8, 2025 By: /s/ William W. Bunker
      Name: William W. Bunker
      Title: Vice Chairman and Chief Financial Officer
        (principal financial and accounting officer)

     

     

    20

     

     

    00-0000000 28125000 P5Y http://fasb.org/srt/2025#ChiefExecutiveOfficerMember 28125000 0002061379 false Q1 --12-31 0002061379 2025-01-01 2025-03-31 0002061379 lwac:UnitsEachConsistingOfOneClassAOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember 2025-01-01 2025-03-31 0002061379 lwac:ClassAOrdinarySharesParValue00001PerShareMember 2025-01-01 2025-03-31 0002061379 lwac:WarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150PerShareMember 2025-01-01 2025-03-31 0002061379 us-gaap:CommonClassAMember 2025-08-07 0002061379 us-gaap:CommonClassBMember 2025-08-07 0002061379 2025-03-31 0002061379 us-gaap:RelatedPartyMember 2025-03-31 0002061379 us-gaap:CommonClassAMember 2025-03-31 0002061379 us-gaap:CommonClassBMember 2025-03-31 0002061379 2025-01-22 2025-03-31 0002061379 us-gaap:CommonClassBMember 2025-01-22 2025-03-31 0002061379 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2025-01-21 0002061379 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-01-21 0002061379 us-gaap:AdditionalPaidInCapitalMember 2025-01-21 0002061379 us-gaap:RetainedEarningsMember 2025-01-21 0002061379 2025-01-21 0002061379 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2025-01-22 2025-03-31 0002061379 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-01-22 2025-03-31 0002061379 us-gaap:AdditionalPaidInCapitalMember 2025-01-22 2025-03-31 0002061379 us-gaap:RetainedEarningsMember 2025-01-22 2025-03-31 0002061379 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2025-03-31 0002061379 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-03-31 0002061379 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0002061379 us-gaap:RetainedEarningsMember 2025-03-31 0002061379 us-gaap:IPOMember 2025-01-26 2025-01-26 0002061379 us-gaap:IPOMember 2025-01-26 0002061379 us-gaap:OverAllotmentOptionMember 2025-01-26 2025-01-26 0002061379 2025-01-26 2025-01-26 0002061379 us-gaap:PrivatePlacementMember 2025-01-01 2025-03-31 0002061379 lwac:ProposedPublicOfferingMember 2025-03-31 0002061379 us-gaap:OverAllotmentOptionMember 2025-03-31 0002061379 us-gaap:PrivatePlacementMember 2025-01-22 2025-03-31 0002061379 us-gaap:PrivatePlacementMember us-gaap:OverAllotmentOptionMember 2025-03-31 0002061379 us-gaap:PrivatePlacementMember lwac:ProposedPublicOfferingMember 2025-03-31 0002061379 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2025-03-31 0002061379 lwac:TrustAccountMember 2025-03-31 0002061379 lwac:TrustAccountMember 2025-01-22 2025-03-31 0002061379 2025-03-31 2025-03-31 0002061379 us-gaap:IPOMember 2025-06-26 2025-06-26 0002061379 us-gaap:IPOMember 2025-06-26 0002061379 2025-06-26 2025-06-26 0002061379 us-gaap:OverAllotmentOptionMember 2025-06-26 2025-06-26 0002061379 2025-06-26 0002061379 us-gaap:CommonClassAMember 2025-06-26 2025-06-26 0002061379 us-gaap:CommonClassAMember us-gaap:IPOMember 2025-06-26 0002061379 lwac:PrivatePlacementWarrantsMember 2025-03-31 0002061379 us-gaap:CommonClassAMember 2025-01-22 2025-03-31 0002061379 lwac:PrivatePlacementWarrantsMember us-gaap:CommonClassAMember 2025-03-31 0002061379 us-gaap:PrivatePlacementMember 2025-03-31 0002061379 us-gaap:OverAllotmentOptionMember 2025-01-22 2025-03-31 0002061379 lwac:SponsorMember us-gaap:OverAllotmentOptionMember 2025-03-31 0002061379 lwac:FounderShareMember us-gaap:CommonClassBMember 2025-01-29 2025-01-29 0002061379 lwac:FounderShareMember us-gaap:CommonClassBMember 2025-01-29 0002061379 lwac:SponsorMember us-gaap:CommonClassBMember 2025-01-29 2025-01-29 0002061379 lwac:SponsorMember 2025-01-29 0002061379 lwac:SponsorMember 2025-03-07 0002061379 lwac:SponsorMember us-gaap:CommonClassBMember 2025-03-07 2025-03-07 0002061379 lwac:SponsorMember us-gaap:CommonClassAMember us-gaap:SubsequentEventMember 2025-05-28 0002061379 lwac:SponsorMember us-gaap:CommonClassBMember us-gaap:SubsequentEventMember 2025-05-28 0002061379 lwac:SponsorMember 2025-05-28 0002061379 lwac:SponsorMember us-gaap:CommonClassAMember 2025-03-31 0002061379 srt:MinimumMember 2025-01-22 2025-03-31 0002061379 srt:MaximumMember 2025-01-22 2025-03-31 0002061379 us-gaap:CommercialPaperMember lwac:SponsorMember 2025-03-31 0002061379 lwac:SponsorMember 2025-03-31 0002061379 srt:ScenarioForecastMember lwac:SponsorMember 2025-06-24 2025-06-24 0002061379 lwac:WorkingCapitalLoansMember lwac:SponsorMember 2025-03-31 0002061379 us-gaap:IPOMember 2025-01-22 2025-03-31 0002061379 lwac:UnderwritersAgreementMember 2025-01-22 2025-03-31 0002061379 us-gaap:CommonClassBMember 2025-01-29 2025-01-29 0002061379 lwac:SponsorMember us-gaap:CommonClassBMember 2025-03-31 0002061379 srt:ScenarioForecastMember us-gaap:CommonStockMember 2025-05-31 0002061379 us-gaap:CommonClassBMember lwac:SponsorMember 2025-05-31 2025-05-31 0002061379 us-gaap:OverAllotmentOptionMember 2025-05-31 2025-05-31 0002061379 srt:ScenarioForecastMember 2025-06-26 2025-06-26 0002061379 lwac:InitialBusinessCombinationMember 2025-03-31 0002061379 lwac:InitialBusinessCombinationMember us-gaap:CommonClassAMember 2025-03-31 0002061379 us-gaap:WarrantMember us-gaap:CommonClassAMember 2025-03-31 0002061379 us-gaap:WarrantMember 2025-01-22 2025-03-31 0002061379 us-gaap:WarrantMember us-gaap:CommonClassAMember 2025-01-22 2025-03-31 0002061379 lwac:RedemptionOfWarrantMember us-gaap:CommonClassAMember 2025-01-22 2025-03-31 0002061379 lwac:SponsorMember us-gaap:SubsequentEventMember 2025-05-31 2025-05-31 0002061379 lwac:SponsorMember us-gaap:SubsequentEventMember 2025-06-26 2025-06-26 0002061379 lwac:SponsorMember us-gaap:SubsequentEventMember 2025-06-26 0002061379 us-gaap:SubsequentEventMember 2025-06-26 0002061379 us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:SubsequentEventMember 2025-06-26 0002061379 us-gaap:MeasurementInputSharePriceMember us-gaap:SubsequentEventMember 2025-06-26 0002061379 us-gaap:SubsequentEventMember 2025-06-24 2025-06-24 0002061379 us-gaap:IPOMember us-gaap:SubsequentEventMember 2025-06-26 2025-06-26 0002061379 us-gaap:IPOMember us-gaap:SubsequentEventMember 2025-06-26 0002061379 us-gaap:OverAllotmentOptionMember us-gaap:SubsequentEventMember 2025-06-24 2025-06-24 0002061379 us-gaap:SubsequentEventMember us-gaap:PrivatePlacementMember 2025-06-26 2025-06-26 0002061379 us-gaap:SubsequentEventMember 2025-06-26 2025-06-26 0002061379 us-gaap:PrivatePlacementMember 2025-06-26 2025-06-26 0002061379 lwac:UnderwritersPrivatePlacementMember 2025-06-26 2025-06-26 0002061379 us-gaap:CommonClassAMember 2025-06-26 0002061379 us-gaap:RelatedPartyMember 2025-06-26 0002061379 lwac:SponsorMember 2025-06-26 0002061379 us-gaap:RelatedPartyMember 2025-06-26 2025-06-26 0002061379 lwac:SponsorMember 2025-06-27 2025-06-27 0002061379 2025-06-27 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure
    Get the next $LWAC alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LWAC

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $LWAC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    LightWave Acquisition Corp. Announces Closing of $215,625,000 Initial Public Offering, Including Full Exercise of Underwriters' Over-Allotment Option

    Dallas, TX, June 26, 2025 (GLOBE NEWSWIRE) -- LightWave Acquisition Corp. (the "Company"), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, today announced the closing of its initial public offering of 21,562,500 units at an offering price of $10.00 per unit. This includes the exercise in full by the underwriters of their over-allotment option to purchase up to an additional 2,812,500 units. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant will entitle the holder thereof to purchase one Class A ordinary share at $11.50 per share. The units are listed on the Nasdaq Global Market ("N

    6/26/25 3:07:28 PM ET
    $LWAC

    LightWave Acquisition Corp. Announces Pricing of $187,500,000 Initial Public Offering

    Dallas, TX, June 24, 2025 (GLOBE NEWSWIRE) -- LightWave Acquisition Corp. (the "Company"), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, today announced the pricing of its initial public offering of 18,750,000 units at an offering price of $10.00 per unit, with each unit consisting of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant, which becomes exercisable 30 days after the completion of the Company's initial business combination, will entitle the holder thereof to purchase one Class A ordinary share at $11.50 per share. The units are expected to trade on the Nasdaq Stock Market LLC ("Nasdaq") und

    6/24/25 6:44:57 PM ET
    $LWAC

    Locust Walk Acquisition Corp.'s Stockholders Approve Business Combination with eFFECTOR Therapeutics to Create Next-Generation Oncology Company Developing New Class of Cancer Therapies

    SAN DIEGO, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Locust Walk Acquisition Corp. (NASDAQ:LWAC) ("LWAC" or the "Company"), a special purpose acquisition company, announced today that the Company's stockholders have approved all proposals related to the previously announced business combination (the "Business Combination") with eFFECTOR Therapeutics, Inc. ("eFFECTOR") at a special meeting of stockholders held on August 24, 2021. Approximately 93.2% of the votes cast at the meeting on the Business Combination proposal, representing approximately 71.7% of LWAC's outstanding shares, voted to approve the Business Combination. LWAC stockholders also voted overwhelmingly to approve the other proposals

    8/24/21 4:47:39 PM ET
    $LWAC

    $LWAC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Dickason Allen Charles

    3 - LightWave Acquisition Corp. (0002061379) (Issuer)

    7/9/25 4:54:59 PM ET
    $LWAC

    Large owner Lightwave Founders Llc bought $6,062,500 worth of Class A ordinary shares (606,250 units at $10.00) (SEC Form 4)

    4 - LightWave Acquisition Corp. (0002061379) (Issuer)

    7/9/25 4:50:58 PM ET
    $LWAC

    SEC Form 3 filed by new insider Lightwave Founders Llc

    3 - LightWave Acquisition Corp. (0002061379) (Issuer)

    6/24/25 9:27:54 PM ET
    $LWAC

    $LWAC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Lightwave Founders Llc bought $6,062,500 worth of Class A ordinary shares (606,250 units at $10.00) (SEC Form 4)

    4 - LightWave Acquisition Corp. (0002061379) (Issuer)

    7/9/25 4:50:58 PM ET
    $LWAC

    $LWAC
    SEC Filings

    View All

    SEC Form 10-Q filed by LightWave Acquisition Corp.

    10-Q - LightWave Acquisition Corp. (0002061379) (Filer)

    8/21/25 5:04:51 PM ET
    $LWAC

    SEC Form NT 10-Q filed by Locust Walk Acquisition Corp.

    NT 10-Q - LightWave Acquisition Corp. (0002061379) (Filer)

    8/14/25 5:26:46 PM ET
    $LWAC

    Amendment: SEC Form SCHEDULE 13G/A filed by Locust Walk Acquisition Corp.

    SCHEDULE 13G/A - LightWave Acquisition Corp. (0002061379) (Subject)

    8/14/25 10:06:25 AM ET
    $LWAC

    $LWAC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Locust Walk Acquisition Corp.

    SC 13D - eFFECTOR Therapeutics, Inc. (0001828522) (Subject)

    9/13/21 6:23:36 AM ET
    $LWAC

    SEC Form SC 13D filed by Locust Walk Acquisition Corp.

    SC 13D - eFFECTOR Therapeutics, Inc. (0001828522) (Subject)

    9/7/21 5:12:00 PM ET
    $LWAC

    SEC Form SC 13D filed by Locust Walk Acquisition Corp.

    SC 13D - eFFECTOR Therapeutics, Inc. (0001828522) (Subject)

    9/3/21 4:00:25 PM ET
    $LWAC